The strongest associations—where C1GALT1 expression correlated with all tested proliferation markers—were found in pancreatic, bladder, and breast cancers, suggesting that C1GALT1 may play a particularly influential role in regulating proliferative capacity in these tumors. Here, C1GALT1 is linked to breast cancer.